Comparison of DNA Extraction Protocols and Molecular Targets to Diagnose Tuberculous Meningitis. (30th May 2017)

• Record Type: Journal Article
• Authors: Palomo, Flavia Silva; Rivero, Martha Gabriela Celle; Quiles, Milene Gonçalves; Pinto, Fernando Pereira; Machado, Antonia Maria de Oliveira; Carlos Campos Pignatari, Antonio
• Other Names: Garzelli Carlo Academic Editor.
• Is Part Of: Tuberculosis research and treatment. Volume 2017(2017)
• Publication Date: 2017-05-30
• Subjects: Tuberculosis -- Periodicals; Tuberculosis -- Prevention -- Periodicals; Tuberculosis -- Treatment -- Periodicals; Tuberculosis -- Social aspects -- Periodicals; 616.995005
• DOI: 10.1155/2017/5089046
• Languages: English
• ISSNs: 2090-150X

Abstract

Abstract : Tuberculous meningitis (TBM) is a severe form of extrapulmonary tuberculosis. The aims of this study were to evaluate in-house molecular diagnostic protocols of DNA extraction directly from CSF samples and the targets amplified by qPCR as an accurate and fast diagnosis of TBM. One hundred CSF samples from 68 patients suspected of TBM were studied. Four DNA extraction techniques (phenol-chloroform-thiocyanate guanidine, silica thiocyanate guanidine, resin, and resin with ethanol) were compared and CSF samples were used to determine the best target ( IS6110, MPB64, and hsp65 KDa ) by qPCR. The extraction protocol using the phenol-chloroform-thiocyanate guanidine showed the best results in terms of quantification and sensitivity of PCR amplification, presenting up to 10 times more DNA than the second best protocol, the silica guanidine thiocyanate. The target that showed the best result for TBM diagnosis was the IS6110 . This target showed 91% sensitivity and 97% specificity when we analyzed the results by sample and showed 100% sensitivity and 98% specificity when we analyzed the results by patient. The DNA extraction with phenol-chloroform-thiocyanate guanidine followed by IS6110 target amplification has been shown to be suitable for diagnosis of TBM in our clinical setting.